The Value of Flow Cytometry Clonality in Large Granular Lymphocyte Leukemia

Valentina Giudice1,2, Matteo D'Addona1,2, Nunzia Montuori3

  • 1Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, 84081 Baronissi, Italy.

Cancers
|September 28, 2021
PubMed

Insights

Flow cytometry Vβ usage effectively identifies clonal T-cell receptor rearrangements in large granular lymphocyte leukemia. This method aids in diagnosing LGL leukemia and monitoring its progression, even in silent underlying hematological conditions.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Large granular lymphocyte (LGL) leukemia is a T or NK cell lymphoproliferative disorder.
  • It often co-occurs with autoimmune diseases and myelodysplastic syndromes.
  • LGL immunophenotype resembles effector memory CD8+ T cells.

Purpose of the Study:

  • To evaluate flow cytometry Vβ usage for identifying T-cell receptor (TCR) clonality in LGL leukemia.
  • To assess the utility of Vβ usage in characterizing LGL clones and monitoring disease kinetics.
  • To explore Vβ usage for detecting silent LGL clones in other hematological conditions.

Main Methods:

  • Flow cytometry analysis of Vβ usage to detect clonal TCR rearrangements at the protein level.
  • Multiparametric staining for immunophenotypic characterization of LGL clones.
  • Monitoring clonal kinetics during treatment and follow-up.

Main Results:

  • Vβ usage by flow cytometry is a fast, sensitive method for identifying clonal TCR rearrangements.
  • This technique allows for immunophenotypic characterization and monitoring of LGL clones.
  • Vβ skewing can reveal recurrent TCR rearrangements linked to aberrant immune responses.

Conclusions:

  • Flow cytometry Vβ usage is a valuable tool for diagnosing and managing LGL leukemia.
  • It can identify LGL clones underlying other hematological conditions.
  • Routine Vβ analysis may aid in understanding immune dysregulation in hematological and autoimmune disorders.